#8 John C. Martin, Ph.D.
Gilead Sciences
This biopharmaceutical company has 14 marketed products and over 4200 employees on four continents. Gilead had almost $8 billion in revenues in 2010.
Gilead Sciences consistently ranks among top performers in the Wealth Creation Index. Among the consistent top performers, Mike Burdi, Applied Finance Group senior analyst, finds a common thread: “Do your customers care whether you stay in business? It’s one thing to say that one is customer-focused; most claim to be as a matter of course. But would your customers really miss not having access to what you offer?” For Gilead customers, that answer is yes.
Score | 2010 Score | % Change In Score | Market Value/Invested Capital | Three-Year EM | EM Change | Mgmt Quality |
---|---|---|---|---|---|---|
92.8 | 86.7 | 7.0% | B | A | A | A |